Psoriasis in Children
Authors:
H. Bučková 1; S. Polášková 2
Authors place of work:
Dětské kožní oddělení PEK FN Brno a LF MU v Brně
primář MUDr. Hana Bučková, Ph. D.
1; Dětská kožní ambulance Dermatovenerologické kliniky VFN a UK, Praha
přednosta prof. MUDr. Jiří Štork, CSc.
2
Published in the journal:
Čes-slov Derm, 88, 2013, No. 2, p. 59-71
Category:
Reviews (Continuing Medical Education)
Summary
Psoriasis is a inflammatory, non-infectious skin disease affecting 1–3% of population. Almost 31–45% of adult psoriasis patients report the onset of the disease in the childhood or before 20 years of age. Psoriasis is a multifactorial disease triggered by various factors in genetically predisposed patients. Psoriasis seriously impacts on the quality of life. In children topical therapy is the mainstay of the treatment. Individual approach to patient is required. Guidelines on juvenile psoriasis treatment does not exist yet. In 2010 and 2011 European experts published the consensus on juvenile psoriasis diagnosis and treatment in JDDG [32, 34]. The graphs from the Delphi study summarizing the answers of 18 European experts in the juvenile psoriasis diagnosis and treatment are shown in this article.
Key words:
juvenile psoriasis – clinical manifestation – diagnosis – differential diagnosis – topical and systemic therapy
Zdroje
1. ABDEL-HAMID, I. A., AGHA, S. A., MOUSTAFA, Y. M. et al. Pityriasis amiantacea: A clinical and etiopathologic study of 85 patients. Int. J. Dermatol., 2003, 42, 4, p. 260–264.
2. ALBRECHT, L., BOURCIER, M. et al. For Canadian Psoriasis Guidelines Comitee Topical psoriasis therapy in the age of biologics. J. Cut. Med. Suzrg., 2011, 15, p. 309–321.
3. ATHERTON, D. J. et al. Phototherapy for children. Pediatr. Dermatol., 1996, 13, p. 415–418.
4. AUGUSTIN, M. et al. Epidemiology and comorbidity of psoriasis in children. Br. J. Dermatol., 2010, 162, p. 633–636.
5. AUGUSTIN, M., REICH, K., GLAESKE, G., SCHAEFER, I., RADTKE, M. Co-morbidity and age-relatied prevalence od psoriasis: Analysis if health insutance data in Germany. Acta Derm. Venereol., 2010, 90, p. 147–151.
6. BENÁKOVÁ, N. Lokální léčba psoriázy I. Čes-slo Derm, 87, 2012. N1, XXIX–XXX.
7. BENOIT, S., HAMM, H. Childhood psoriasis. Clinics in Dermatology, 2007, 25, p. 555–562.
8. BERRETA-PICCOLI, B. C., SAUVAIN, M. J., GAL, I. et al. Synovitis, acne pustulosis hyperostosis, osteitis (SAPHO) syndrom in childhood: A report of ten cases and review of the literature. Eur. J. Pediatr., 2000, 159, 8, p. 594–601.
9. BEYLOT, C. et al. Particular clinical features of psoriasis in infants and children. Acta Derm. Veneorol., Suppl. 1979, 87, p. 95–97.
10. BOWCOCK, A. M., BARKER, J. N. Genetics of psoriasis: The potential impact on new therapies. J. Am. Acad. Dermatol., 2003, 49, 2 Suppl, S51–S56.
11. BRECHER, A. R., ORLOW S. J. Oral retinoid therapy for dermatologic conditions in children and adolescents. J. Am. Acad. Dermatol., 2003, 49, 2, p. 171–182.
12. BRIGHT, R. D. Methotrexate in the treatment of psoriasis. Cutis, 1999, 64, 5, p. 332–334.
13. BRUNE, A., MILLER, D. W., LIN, P., COTRIM-RUSSI, D., PALLER, A. S. Tacrolimus ointment is effective for psoriasis on the face and intertriginous areas in pediatric patients. Pediatr. Dermatol., 2007, 24.
14. BURDEN, A. D. Management of psoriasis in childhood. Clin. Exp. Dermatol., 1999, 24, p. 341–345.
15. CASSANDRA, M., CONTE, E., CORTEZ, B. Childhood pustular psoriasis elicited by the streptococcal antigen: a case report and review of the literature. Pediatr. Dermatol., 2003, 20, p. 506–510.
16. CETKOVSKÁ, P., KOJANOVÁ, M. Česká doporučení k biologické léčbě závažné chronické ložiskové psoriázy. Čes-slov Derm., 87, 2012, N1, I–XXII.
17. DE JAGER, M. E. A. et al. Efficacy and safety of treatments for childhood psoriasis: Asystematic literature reviw. J. Am. Acad. Dermatol., June 2010, p. 1013–1030.
18. DUHRA, P. Treatment of gastrointestinal symptoms associated with methotrexate therapy for psoriasis. J. Am. Acad. Dermatol., 1993, 28, 3, p. 466–469.
19. FARBER, E. M., NALL, L. Childhood psoriasis. Cutis, 1999, 64, p. 309–314.
20. HERCOGOVÁ, J. Psoriasis. Čes. Dermatovenerologie, 2011, 1, 1, p. 8–21.
21. HONIG, P. J. Guttate psoriasis associated with perianal streptococcal disease. J. Pediatr., 1988, 113, p. 1037–1039.
22. JAIN, V. K., AGGARWAL, K., JAIN, K., BANSAL, A. Narrow-band UV-B phototherapy in childhood psoriasis. Int. J. Dermatol., 2007, 46, p. 320–322.
23. KILIC, S. S., HACIMUSTAFAOGLU, M., CELEBI, S. et al. Low dose Cyclosporin A treatment in generalized pustular psoriasis. Pediatric. Dermatol., 2001, 18, 3, p. 246–248.
24. KRUTMANN, J., MORITA, A. Mechanism of ultraviolet (UV) B and UVA phototherapy. J. Invest. Dermatol. Sym. Proc., 1999, 4, p. 70–72.
25. LEBWOHL, M., ALI, S. Treatment of psoriasis. Part 1. Topical therapy and phototherapy. J. Am. Acad. Dermatol., 2001, 45, 4, p. 487–498.
26. LEMAN, J., BURDEN, D. Psoriasis in children, a guide to it. diagnosis and management. Paediatr. Drugs, 2001, 3, p. 673–680.
27. LIAO, P. B., RUBINSON, R., HOWARD, R. et al. Annular pustular psoriasis – most common formof pustular psoriasis in children: Report of three cases and review od the literature. Pediatr. Dermatol., 2002, 19, 1, p. 19–25.
28. LIN, P., PALLER, A. S. Pediatric psoriasis. In Weinstein, G. D., Gottleib, A. B., editors. Psoriasis. New York: Marcel Dekker, 2003, p. 197–218.
29. LUGER, T., PAUL, C. Potential new indications of topical calcineurin inhibitors. Dermatology, 2007, 215, p. 45–54.
30. MORRIS, A., ROGERS, M., FISCHER, G. et al. Childhood psoriasis: A clinical review of 1262 cases. Pediatr. Dermatol., 2001, 18, 3, p. 188-198.
31. MROWIETZ, U., KRAGBALLE, K., NAST, A. et al. Strategies for improving the quality of care in psoriasis with the use of treatment goals – a report on an implementation meeting. J. Eur. Acad. Dermatol., 2011, 25, suppl. 3, p. 1–13.
32. ORFANOS, C. E. Treatment of psoriasis with retinoids: present status. Cutis, 1999, 64, 5, p. 347–353, 76–80.
33. PALLER, A. S., MANCINI, A. J. Hurwitz Clinical Pediatric Dermatology. Fourth edition, Elsevier Saunders, 2011, p. 71–80.
34. PALLER, A. S., SIEGFRIED, E. C., LANGLEY, R. G. et al. Etanercept Treatment for Children and Adolescents with Plaque Psoriasis. N. Engl. J. Med., 358, 3, 2008, January 17, p. 241–251.
35. PARK, S. B., SUH, D. H., YOUN, J. I. A pilot study to assess the safety and efficacy of topical calcipotriol treatment in childhood psoriasis. Pediatr. Dermatol., 1999, 16, p. 321–325.
36. PASIC, A., CEOVIC, R., LIPOZENCIC, J. et al. Phototherapy in pediatric patiens. Pediatr. Dermatol., 2003, 20, p. 71–77.
37. PERRET, C. M., ILCHYSHYN, A., BEARTH-JONES, J. Cyclosporin in childhood psoriasis. J. Dermatol. Treat., 2003,14, 2, p. 113–118.
38. PETTY, R. E., SOUTHWOOD, T. R., BAUM, J. et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J. Rheumatol., 1998, 25, 10, p. 1991–1994.
39. REYCHAUDHURI, S. P., GROSS, J. A comparative study of pediatric onset psoriasis. Pediatr. Dermatol., 2000, 17, 3, p. 174–178.
40. ROGERS, M. Childhood psoriasis. Carr. Opin. Pediatr., 2002, 1, p. 404–409.
41. SAGGESE, G., FEDERICO, G., BATTINI, R. Topical application of 1,25-dihydroxyvitamin D3 (Calcitriol) is an effective and reliable therapy to cure skin lesions in psoriasis children. Eur. J. Pediatr., 1993, 152, p. 389–392.
42. SCHMITT, J., APFELBACHER, C. Epidemiology of pediatric psoriasis. A representative German cross-sectional study. Exp. Dermatol., 2010, 19, p. 219.
43. STAHLE, M. ET AL. Juvenile psoriasis and its clinical management: a European expert group consensus. JDDG, 2010, 8, p. 812–818.
44. STERN, R. S., NICHOLS, K. T. Therapy with orally administered methoxsalen and ultraviolet A radiation during childhood increases the risk of basal cell carcinoma. The PUVA Follow-up Study. J. Pediatr., 1996, 129, 6, p. 915–917.
45. STICHERLING, M. et al. Therapy of psoriasis in childhood and adolescence – a German expert konsensus. JDDG, 2011, 9, p. 815–823.
46. SWANBECK, G., INEROT, A., MARTINSSON, T., WAHLSTROM, J., ENERBACK, F., YHR, M. Age at onset and different types of psoriasis. Br. J. Dermatol., 1995, 133, p. 768–773.
47. TWILT, M., SWART VAN DEN BERG, M., VAN MEURS, J. C. et al. Persisting uveitis antedating psoriasis in two boys. Eur. J. Pediatr., 2003, 162, 9, p. 607–609.
48. WILSON, J. K., AL-SUWAIDAN, S. N., KROWCHUK, D. et al. Treatment of psoriasis in children: Is there a role for antibiotic therapy and tonsillectomy? Pediatr. Dermatol., 2003, 20, 1, p. 11–15.
49. ZAMBERK, P., VÉLAZQUEZ, D., CAMPOS, M., HERNANZ, J., LÁZARO, P. Paediatric psoriasis – narrowband UVB treatment. J. Eur. Acad. Dermatol. Venereol., 2010, 24, p. 415–419.
Štítky
Dermatology & STDs Paediatric dermatology & STDsČlánok vyšiel v časopise
Czech-Slovak Dermatology
2013 Číslo 2
Najčítanejšie v tomto čísle
- Current Possibilities of Infantile Haemangioma Treatment
- Psoriasis in Children
- Trends in the Development of Contact Sensitivity to Selected Additives of Pharmaceutical and Cosmetic Products in the Czech Republic